voice searchcamera search
Imatib 400 Mg Tablets - Imatinib Mesylate, Cipla Manufactured, Cancer Treatment | Leukemia Targeted, Generic Gleevec

Imatib 400 Mg Tablets - Imatinib Mesylate, Cipla Manufactured, Cancer Treatment | Leukemia Targeted, Generic Gleevec

Get Latest Price

Brand Name :

Imatib

In Stock

In Stock

Product Specifications

Dosage400mg
FormTablets
Active IngredientImatinib Mesylate
ManufacturerCipla
PackagingCarton
StorageRoom temperature
BrandGeneric Gleevec
FeaturesCancer treatment, Targets leukemia, 400mg dosage, Effective, Generic Gleevec, Cipla manufactured

Company Details

Located in New Delhi, India, Modern Times Helpline Pharma is one of the licensed pharmaceutical wholesale companies dealing in a range of effective medicines. We have license by the Indian FDA / drug controller as a registered Supplier, Stockist, Wholesaler and Exporter of result oriented pharmaceutical products. We are a key Stockist and Supplier with the import export certification issued by Ministry of Commerce (Govt. of India). Since 2012, we have been engaged in the domain of Wholesale Anti Cancer Medicines

Business Type

Exporter, Manufacturer, Distributor, Supplier

Employee Count

10

Establishment

2012

Working Days

Monday To Sunday

GST NO

07AJZPJ6960A1ZV

Related Products

Explore Related Categories

More Products From This Seller

Seller Details

GST

GST - 07AJZPJ6960A1ZV

Delhi, Delhi

Name

Mr Kamal Jindal

Address

5A/7,Ground Floor, Ansari Road, Darya Ganj, Delhi, Delhi, 110002, India

imatinib drug in Delhi

Report incorrect details

Compare With Similar Products

Buyer Feedback

4

Origin Of Medicine

Synthetic

India

Pacakaging (Quantity Per Box)

1 bottle per box

3 strips of 10 tablets each (30 tablets per box)

Salt Composition

Afatinib Dimaleate

Imatinib Mesylate IP 400 mg

Drug Type

Targeted Therapy, Other

Other, Prescription medicine

Ingredients

Afatinib Dimaleate

Imatinib Mesylate

Physical Form

Tablets

Tablets

Function

Treatment of non-small cell lung cancer (NSCLC), Other

Other, Anticancer, Tyrosine kinase inhibitor

Recommended For

Patients diagnosed with advanced or metastatic NSCLC with specific EGFR mutations

Adults and children with specific cancer indications

Dosage

30 mg per tablet

As directed by the physician

Dosage Guidelines

Take one tablet daily on an empty stomach or as directed by a physician

Follow medical advice; do not exceed prescribed amount

Suitable For

Adults

Other, Adults & Children

Quantity

1 bottle containing 30 tablets

10 tablets per strip

Storage Instructions

Store in a cool dry place below 30AdegC away from light and moisture

Store below 30AdegC, protect from moisture and light